Oncologic outcomes of de-escalating axillary treatment in clinically node-positive breast cancer patients treated with neoadjuvant systemic therapy – A two center cohort study-Reference-Cited by-同舟云学术

Oncologic outcomes of de-escalating axillary treatment in clinically node-positive breast cancer patients treated with neoadjuvant systemic therapy – A two center cohort study

Published:2024-09 Issue:9 Volume:50 Page:108472
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Schipper Robert-Jan^ORCID,de Bruijn Anne,van der Sangen Maurice J.C.^ORCID,Bloemen Johanne G.,van den Hoven Ingrid,Schepers Ester E.M.^ORCID,Vriens Birgit E.P.,Boerman Thom,Rijkaart Dorien C.,van de Winkel Linda M.H.,Brouwer Christel,van Warmerdam Laurence J.C.^ORCID,Gielens Maaike P.M.,van Bommel Rob M.G.,van Riet Yvonne E.,Voogd Adri C.^ORCID,Nieuwenhuijzen Grard A.P.^ORCID

Publisher

Elsevier BV

Reference31 articles.

1. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes;von Minckwitz;J Clin Oncol,2012

2. A prospective, multicenter registry study to evaluate the clinical feasibility of targeted axillary dissection (TAD) in node-positive breast cancer patients;Kuemmel;Ann Surg,2022

3. Axillary pathologic complete response after neoadjuvant systemic therapy by breast cancer subtype in patients with initially clinically node-positive disease: a systematic review and meta-analysis;Samiei;JAMA Surg,2021

4. Diagnostic performance of noninvasive imaging for assessment of axillary response after neoadjuvant systemic therapy in clinically node-positive breast cancer: a systematic review and meta-analysis;Samiei;Ann Surg,2021

5. Axillary response monitoring after neoadjuvant chemotherapy in breast cancer: can we avoid the morbidity of axillary treatment?;Vugts;Ann Surg,2014